Immunosuppression in Glomerular Diseases: Implications for SARS-CoV-2 Vaccines and COVID-19

Bibliographic Details
Main Author: Michael R. Yeaman
Format: Article
Language:English
Published: Karger Publishers 2021-08-01
Series:Glomerular Diseases
Online Access:https://www.karger.com/Article/FullText/519182
id doaj-8fdf8977ef5a4ac5a173d712fbdae481
record_format Article
spelling doaj-8fdf8977ef5a4ac5a173d712fbdae4812021-09-23T10:59:44ZengKarger PublishersGlomerular Diseases2673-36332021-08-0110.1159/000519182519182Immunosuppression in Glomerular Diseases: Implications for SARS-CoV-2 Vaccines and COVID-19Michael R. Yeamanhttps://www.karger.com/Article/FullText/519182
collection DOAJ
language English
format Article
sources DOAJ
author Michael R. Yeaman
spellingShingle Michael R. Yeaman
Immunosuppression in Glomerular Diseases: Implications for SARS-CoV-2 Vaccines and COVID-19
Glomerular Diseases
author_facet Michael R. Yeaman
author_sort Michael R. Yeaman
title Immunosuppression in Glomerular Diseases: Implications for SARS-CoV-2 Vaccines and COVID-19
title_short Immunosuppression in Glomerular Diseases: Implications for SARS-CoV-2 Vaccines and COVID-19
title_full Immunosuppression in Glomerular Diseases: Implications for SARS-CoV-2 Vaccines and COVID-19
title_fullStr Immunosuppression in Glomerular Diseases: Implications for SARS-CoV-2 Vaccines and COVID-19
title_full_unstemmed Immunosuppression in Glomerular Diseases: Implications for SARS-CoV-2 Vaccines and COVID-19
title_sort immunosuppression in glomerular diseases: implications for sars-cov-2 vaccines and covid-19
publisher Karger Publishers
series Glomerular Diseases
issn 2673-3633
publishDate 2021-08-01
url https://www.karger.com/Article/FullText/519182
work_keys_str_mv AT michaelryeaman immunosuppressioninglomerulardiseasesimplicationsforsarscov2vaccinesandcovid19
_version_ 1717370539490672640